Institutional Ownership
Corcept Therapeutics Inc
CUSIP 218352102COMCORTQ1 2026
13D / 13G Filings
38
Schedule 13D/13G on record
Beneficial Filers
12
Distinct reporting persons
Largest Stake
15.9%
Max % of class reported
Institutional Holders
340
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
38 filings · latest Feb 12, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 12, 2026 | Renaissance Technologies LLC | 13G/A | 5.5% | 5.76M | SEC |
| 2 | Jul 17, 2025 | Blackrock, Inc. | 13G/A | 10.9% | 11.54M | SEC |
| 3 | Apr 23, 2025 | Blackrock, Inc. | 13G/A | 12.7% | 13.35M | SEC |
| 4 | Feb 21, 2025 | Ingalls &Amp; Snyder LLC | 13G/A | 7.8% | 8.17M | SEC |
| 5 | Feb 14, 2025 | Joseph K. Belanoff | 13G/A | 6.3% | — | SEC |
| 6 | Mar 27, 2024 | Ingalls & Snyder LLC | 13G/A | 8.0% | 8.26M | SEC |
| 7 | Feb 14, 2024 | Baker G Leonard Jr | 13G/A | 5.3% | 5.51M | SEC |
| 8 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 9.3% | 9.54M | SEC |
| 9 | Feb 13, 2024 | Renaissance Technologies LLC | 13G/A | 6.5% | 6.73M | SEC |
| 10 | Feb 12, 2024 | Belanoff Joseph K | 13G/A | 6.1% | 6.58M | SEC |
28 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Corcept Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 12.15M | $489.82M |
| 2 | Renaissance Technologies LLC | 5.68M | $229.07M |
| 3 | Parallel Advisors, LLC | 3.98M | $160.33M |
| 4 | State Street Corp | 3.20M | $129.03M |
| 5 | Fmr LLC | 3.19M | $128.60M |
| 6 | Geode Capital Management, LLC | 2.71M | $109.40M |
| 7 | First Trust Advisors LP | 2.17M | $87.61M |
| 8 | Dimensional Fund Advisors LP | 1.55M | $62.60M |
| 9 | Tang Capital Management LLC | 1.50M | $60.47M |
| 10 | Ubs Group AG | 1.36M | $54.97M |